Microenvironments of tumor nodules in HNSCC reveal an increased content of CD86+-activated and CD86+CD21-antigen-presenting B cells, as well as IgD-CD27+ memory B cells [83]. The gene discussed is CD27; the disease is head and neck squamous cell carcinoma.